rivaroxaban
bayer
['invictus', 'rivaroxaban']
 invictus trial: in #rheumatic af, vkas proved better than #rivaroxaban for cv events or #death, with similar bleeding. drug discontinuation was also more common with rivaroxaban.
#esc2022 #esccongress2022 
MD | PhD | Assistant Professor | Cardiologist | #univanvitelli